EquityZen Growth Technology Fund LLC - Series 2058
Raised
$190K
Investors
16
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2058 is a Delaware-domiciled pooled investment fund managed by EquityZen Advisors, raising capital under Rule 506(b) and Section 3(c)(1). The vehicle raised $190K from 16 investors with a $10K minimum investment. This is part of EquityZen's pre-IPO secondary platform with 1,889 related EDGAR entities.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption pattern common to private secondary market vehicles. The $10K minimum investment represents a relatively accessible entry point for accredited investors in the pre-IPO category, consistent with EquityZen's platform strategy of fractionalizing access to private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
